“The FDA Bad Ad Program and Prescription Drug Promotion”
Event Navigation
The U.S. Food and Drug Administration (FDA)* through a contract from the U.S. Department of Health and Human Services presents…“The FDA Bad Ad Program and Prescription Drug Promotion”
This activity will educate a national audience of healthcare professionals about the FDA Bad Ad program. It will also educate the nation’s healthcare professionals about prescription drug advertising and promotion.
Learning Objectives | Upon completion of this activity, participants will be able to:
- Identify the role that FDA’s Office of Prescription Drug Promotion, or OPDP, plays in regulating prescription drug promotion and advertising.
- Recognize persuasive techniques commonly used in advertising and promotion.
- Describe the most common regulatory issues raised by prescription drug promotion.
- Recognize potentially false or misleading prescription drug promotion.
- Locate the Bad Ad contact information.
- Translate knowledge into action and report potentially problematic prescription drug promotion to OPDP.
Presenters: Dean Robert, Elaine Frost, Ankur Kalola, Jina Kwak, Hailey Lee, Sophia Ni, Meeta Patel, Elizabeth Pepinsky, Meena Savani, Rachel Shaw
Target Audience: This activity is intended for physicians, physician assistants, nurses, pharmacists, pharmacy technicians, certified public health professionals, other health care professionals, and students.
Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the U.S. Food and Drug Administration (FDA). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. To receive your certificate for CE credit, you must complete the post-test and receive a score of 80% or better and complete an evaluation form. Other users may complete the evaluation and print a Certificate of Completion.
Continuing Education Credits (CE) Released: 07/13/2020; Valid for credit through: 07/13/2023
Handouts and Resources:
Please note that the preload and autoplay function for videos and audios is disabled for iOS devices using Safari on cellular networks, and requires a manual playback using the onscreen controls. For additional information, please refer to Apple’s Safari HTML 5 Audio and Video Guide.
Questions? Contact: druginfo@fda.hhs.gov | Toll Free (855) 543-3784, or (301) 796-3400
*NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach
